Friday, September 18th | 29 Elul 5780

Subscribe
August 25, 2020 10:02 am

IIA Launches Bio-Convergence Grant for Israeli-South Korean Collaborations

avatar by CTech Staff

Israeli President Reuven Rivlin and South Korean President Moon Jae-in meet at the Blue House in Seoul, July 15, 2019. Photo: Kobi Gideon / GPO.

CTech – Israeli government investment arm the Israel Innovation Authority (IIA) through the Korea-Israel R&D Foundation announced Tuesday the launch of an open call for bio-convergence projects that include collaborations between Israeli and South Korean companies.

Projects in the following areas of bio-convergence will be considered for a grant: nanorobotics for bio-advanced engineered drug delivery and diagnostics systems, advanced therapeutics discovery systems, tissue engineering, bio-electronics and electroceuticals, and bio-sensors and hybrid devices.

IIA will choose up to two projects for grants of up to NIS 7 million (approximately $2 million) to cover up to 50% of each project’s research and development expenses.

“Leadership in groundbreaking bio-convergence technologies requires a combination of Israeli and international technological expertise in the fields of engineering and biology. To this end, the International Collaboration Division at the Israel Innovation Authority is utilizing a variety of tools in conjunction with leading global partners in this field,” Avi Luvton, VP International Collaboration Division at the Israel Innovation Authority said in a statement.

“This includes Korea, with whom the Authority operates a bi-national foundation to support groundbreaking projects — which will also serve as platform to promote excellence in bio-convergence,” he added.

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

Algemeiner.com

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.